Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Other Accumulated Expenses (2010 - 2026)

Updated

Northwest Biotherapeutics' Other Accumulated Expenses was $6.7 million in Q2 2026, down 8.5% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Northwest Biotherapeutics came in at $8.35 million.

  • The Q2 2026 figure marks the lowest quarterly Other Accumulated Expenses since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.70 Mn
Mar 31, 2026 7.32 Mn
Dec 31, 2025 8.35 Mn
Sep 30, 2018 6.20 Mn
Jun 30, 2018 6.20 Mn
Mar 31, 2018 6.20 Mn
Dec 31, 2017 6.20 Mn
Sep 30, 2017 6.20 Mn
Jun 30, 2017 6.20 Mn
Mar 31, 2017 22.54 Mn
Dec 31, 2016 6.20 Mn
Sep 30, 2016 11.85 Mn
Jun 30, 2016 7.58 Mn
Mar 31, 2016 6.37 Mn
Dec 31, 2015 6.20 Mn
Sep 30, 2015 7.22 Mn
Jun 30, 2015 6.20 Mn
Mar 31, 2015 6.20 Mn
Dec 31, 2014 6.20 Mn
Mar 31, 2012 1.01 Mn
API Access

Northwest Biotherapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NWBO&period=max&api_key=YOUR_API_KEY